| 1 |
Rubio CA, Vieth M, Lang-Schwarz C. The frequency of dysplastic branching crypts in colorectal polypoid tubular adenomas. Int J Exp Pathol 2023. [PMID: 36734673 DOI: 10.1111/iep.12466] [Reference Citation Analysis]
|
| 2 |
Wagner S, Beger NT, Matschos S, Szymanski A, Przybylla R, Bürtin F, Prall F, Linnebacher M, Mullins CS. Tumour-Derived Cell Lines and Their Potential for Therapy Prediction in Patients with Metastatic Colorectal Cancer. Cancers (Basel) 2021;13:4717. [PMID: 34572946 DOI: 10.3390/cancers13184717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Billant O, Friocourt G, Roux P, Voisset C. p53, A Victim of the Prion Fashion. Cancers (Basel) 2021;13:E269. [PMID: 33450819 DOI: 10.3390/cancers13020269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Prall F, Hühns M. Quantitative evaluation of TP53 immunohistochemistry to predict gene mutations: lessons learnt from a series of colorectal carcinomas. Human Pathology 2019;84:246-53. [DOI: 10.1016/j.humpath.2018.10.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 5 |
Naka T, Iwamoto Y, Shinohara N, Chuman H, Tsuneyoshi M. p53 Accumulation in Malignant Bone Tumors: An Immunohistochemical Analysis of 217 Cases. Int J Surg Pathol 1997;5:1-9. [DOI: 10.1177/106689699700500101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 6 |
Mampaey E, Fieuw A, Van Laethem T, Ferdinande L, Claes K, Ceelen W, Van Nieuwenhove Y, Pattyn P, De Man M, De Ruyck K, Van Roy N, Geboes K, Laurent S. Focus on 16p13.3 Locus in Colon Cancer. PLoS One 2015;10:e0131421. [PMID: 26222184 DOI: 10.1371/journal.pone.0131421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 7 |
Tomono A, Itoh T, Yanagita E, Imagawa N, Kakeji Y. Cell cycle kinetic analysis of colorectal neoplasms using a new automated immunohistochemistry-based cell cycle detection method. Medicine (Baltimore) 2015;94:e501. [PMID: 25634203 DOI: 10.1097/MD.0000000000000501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Shetty S, Thomas P, Ramanan B, Sharma P, Govindarajan V, Loggie B. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis. Journal of Surgical Research 2013;180:97-103. [DOI: 10.1016/j.jss.2012.10.053] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 9 |
Kabaker K, Shell K, Kaufman HL. Vaccines for colorectal cancer and renal cell carcinoma. Cancer J 2011;17:283-93. [PMID: 21952277 DOI: 10.1097/PPO.0b013e318232ff44] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 10 |
Scott N, Martin I, Jack AS, Dixon MF, Quirke P. Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia. Clin Mol Pathol 1996;49:M151-8. [PMID: 16696064 DOI: 10.1136/mp.49.3.m151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 11 |
Faro A, Boj SF, Clevers H. Fishing for intestinal cancer models: unraveling gastrointestinal homeostasis and tumorigenesis in zebrafish. Zebrafish 2009;6:361-76. [PMID: 19929219 DOI: 10.1089/zeb.2009.0617] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 12 |
Kim B, Byun SJ, Kim YA, Kim JE, Lee BL, Kim WH, Chang MS. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology. 2010;42:58-65. [PMID: 20025482 DOI: 10.3109/00313020903356392] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 13 |
Sanefuji K, Kayashima H, Iguchi T, Sugimachi K, Yamashita Y, Yoshizumi T, Soejima Y, Nishizaki T, Taketomi A, Maehara Y. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. J Surg Oncol 2009;99:32-7. [DOI: 10.1002/jso.21176] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 14 |
COLORECTAL CANCER: EPIDEMIOLOGY, AETIOLOGY, PATHOLOGY, STAGING SYSTEMS, CLINICAL FEATURES, DIAGNOSIS. Surgery of the Anus, Rectum & Colon 2008. [DOI: 10.1016/b978-0-7020-2723-9.50032-4] [Reference Citation Analysis]
|
| 15 |
Shanmugam C, Katkoori VR, Jhala NC, Grizzle WE, Siegal GP, Manne U. p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior. J Histochem Cytochem 2008;56:305-12. [PMID: 18071066 DOI: 10.1369/jhc.7A7362.2007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 16 |
Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15:1443-1450. [PMID: 16896030 DOI: 10.1158/1055-9965.epi-06-0144] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 17 |
Kashiwagi H, Spigelman AD, Talbot IC, Phillip RKS. Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis: p53 OVEREXPRESSION AND DUODENAL MALIGNANCY. Br J Surg 1996;83:225-8. [DOI: 10.1046/j.1365-2168.1996.02135.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 18 |
Sipos F, Molnár B, Zágoni T, Berczi L, Tulassay Z. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis Colon Rectum 2005;48:775-86. [PMID: 15747078 DOI: 10.1007/s10350-004-0831-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 19 |
Feil G, Krause FS, Zumbraegel A, Wechsel HW, Bichler KH. Ki67, p53, nm23, and DNA cytometry in bladder cancer: potential markers for detection of recurrence? Adv Exp Med Biol 2003;539:99-109. [PMID: 15088899 DOI: 10.1007/978-1-4419-8889-8_8] [Reference Citation Analysis]
|
| 20 |
Sheikh RA, Min BH, Yasmeen S, Teplitz R, Tesluk H, Ruebner BH, Tobi M, Hatfield J, Fligiel S, Lawson MJ. Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas. Dig Dis Sci 2003;48:223-9. [PMID: 12645814 DOI: 10.1023/a:1021727608133] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 21 |
Hosaka S, Aoki Y, Akamatsu T, Nakamura N, Hosaka N, Kiyosawa K. Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas. Cancer 2002;94:219-27. [PMID: 11815980 DOI: 10.1002/cncr.10198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 22 |
Porcelli B, Frosi B, Terzuoli L, Arezzini L, Marinello E, Vernillo R, De Martino A, Vatti R, Minacci C. Expression of p185 and p53 in benign and malignant colorectal lesions. Histochem J 2001;33:51-7. [PMID: 11352401 DOI: 10.1023/a:1017543930661] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 23 |
Sánchez-Fayos Calabuig P, Juzgado Lucas D, Bosch Esteva O, González Guirado A, Porres Cubero JC. [Colorectal cancer: inducing circumstances (etiology) and pathogenic paths (pathogenesis]. Rev Clin Esp 2000;200:605-16. [PMID: 11196590 DOI: 10.1016/s0014-2565(00)70019-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 24 |
Park SW, Kim YB, Hwang SN, Choi DY, Kwon JT, Min BK, Suk JS. The effects of N-methyl-N-nitrosourea and azoxymethane on focal cerebral infarction and the expression of p53, p21 proteins. Brain Res 2000;855:298-306. [PMID: 10677604 DOI: 10.1016/s0006-8993(99)02384-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 25 |
Yao T, Kajiwara M, Kouzuki T, Iwashita A, Tsuneyoshi M. Villous tumor of the colon and rectum with special reference to roles of p53 and bcl-2 in adenoma-carcinoma sequence. Pathol Int 1999;49:374-82. [PMID: 10417679 DOI: 10.1046/j.1440-1827.1999.00881.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 26 |
Yao T, Kouzuki T, Kajiwara M, Matsui N, Oya M, Tsuneyoshi M. 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential. J Pathol 1999;187:511-7. [PMID: 10398114 DOI: 10.1002/(SICI)1096-9896(199904)187:5<511::AID-PATH308>3.0.CO;2-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 27 |
Hayakawa M, Shimokawa K, Kusugami K, Sugihara M, Morooka Y, Fujita T, Nakamura M, Nishio Y, Maeda K, Ando T, Peek RM. Clinicopathological features of superficial depressed-type colorectal neoplastic lesions. Am J Gastroenterol 1999;94:944-9. [PMID: 10201461 DOI: 10.1111/j.1572-0241.1999.991_n.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 28 |
Clausen OP, Lothe RA, Børresen-Dale AL, De Angelis P, Chen Y, Rognum TO, Meling GI. Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas. Diagn Mol Pathol 1998;7:215-23. [PMID: 9917132 DOI: 10.1097/00019606-199808000-00006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 29 |
Iwao T, Hanada K, Tsuchida A, Hirata M, Eguchi N, Kajiyama G. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations. Cancer 1998;82:1487-94. [PMID: 9554525 DOI: 10.1002/(sici)1097-0142(19980415)82:8<1487::aid-cncr9>3.0.co;2-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 30 |
Akiyama Y, Yagi OK, Ishikawa T, Nagasaki H, Saitoh K, Yuasa Y. Genetic alterations are frequent in APC but rare in the TGF-beta type II receptor gene in cancer in adenomas of the colon. Cancer Lett 1998;125:89-96. [PMID: 9566701 DOI: 10.1016/s0304-3835(97)00490-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 31 |
Heidenreich A, Schenkman NS, Sesterhenn IA, Mostofi KF, Moul JW, Srivastava S, Engelmann UH. Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours. APMIS 1998;106:90-9; discussion 99-100. [PMID: 9524567 DOI: 10.1111/j.1699-0463.1998.tb01324.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 32 |
Wilentz RE, Slebos RJC, Hruban RH. Screening for Pancreatic Cancer Using Techniques to Detect Altered Gene Products. Pancreatic Cancer 1998. [DOI: 10.1007/978-1-4612-1810-4_6] [Reference Citation Analysis]
|
| 33 |
Wolf JC, Ginn PE, Homer B, Fox LE, Kurzman ID. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors. Vet Pathol 1997;34:394-404. [PMID: 9381650 DOI: 10.1177/030098589703400503] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 34 |
Oka M, Kounoura K, Narasaki F, Sakamoto A, Fukuda M, Matsuo I, Ikeda K, Tsurutani J, Ikuno N, Omagari K, Mizuta Y, Soda H, Gudas JM, Kohno S. P-glycoprotein is positively correlated with p53 protein accumulation in human colorectal cancers. Jpn J Cancer Res 1997;88:738-42. [PMID: 9330605 DOI: 10.1111/j.1349-7006.1997.tb00445.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 35 |
Yagi K, Kunitomo K, Ii K, Tashiro S. Relationship of P-glycoprotein and p53 protein to chemosensitivity in colorectal cancer. Int J Clin Oncol 1997;2:81-91. [DOI: 10.1007/bf02488878] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 36 |
Tomita T. p53 and proliferating cell nuclear antigen in endocrine tumors of pancreas and intestinal carcinoids. Pathology 1997;29:147-53. [PMID: 9213333 DOI: 10.1080/00313029700169774] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 37 |
Monica B, Barbieri A, Cortellini P. Biological prognostic factors in renal cell carcinoma. Urologia 1997;64:196-204. [DOI: 10.1177/039156039706400206] [Reference Citation Analysis]
|
| 38 |
Cortellini P, Monica B, Barbieri A, Camisa R, Bozzetti C, Guazzi A, Di Stefano C, Borrini A, Martella E, Crafa P. Biological prognostic factors in renal cell carcinoma: Personal experience. Urologia 1997;64:205-209. [DOI: 10.1177/039156039706400207] [Reference Citation Analysis]
|
| 39 |
Nio Y, Sato Y, Song M-, Sumi S-, Minari Y, Yano S, Tamura K. Ki-ras point mutation in codon 12 and expression ofp53 in mucin-producing tumor of the pancreas. J Hep Bil Pancr Surg 1997;4:83-90. [DOI: 10.1007/bf01211347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 40 |
Ge C, He S, Tian Y, Qu H, He A. Expression of p53 protein in cancers of small intestine and its relationship to clinical course and prognosis. Chin J Cancer Res 1997;9:49-52. [DOI: 10.1007/bf02974722] [Reference Citation Analysis]
|
| 41 |
Yao T, Utsunomiya T, Nagai E, Oya M, Tsuneyoshi M. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma. Pathol Int 1996;46:962-7. [PMID: 9110348 DOI: 10.1111/j.1440-1827.1996.tb03575.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 42 |
Densmore TL, Langer JC, Molleston JP, Dehner LP, Coffin CM. Colorectal adenocarcinoma as a second malignant neoplasm following Wilms' tumor and rhabdomyosarcoma. Med Pediatr Oncol 1996;27:556-60. [PMID: 8888817 DOI: 10.1002/(SICI)1096-911X(199612)27:6<556::AID-MPO9>3.0.CO;2-K] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 43 |
Rew DA, Karkera R, Mullee MA, Julious SA, Wilson GD. The flow cytometric analysis of total p53 protein content and proliferation indices in colorectal cancer, in relation to clinical outcome. Eur J Surg Oncol 1996;22:508-15. [PMID: 8903495 DOI: 10.1016/s0748-7983(96)93027-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 44 |
Papadopoulos I, Rudolph P, Wirth B, Weichert-Jacobsen K. p53 expression, proliferation marker Ki-S5, DNA content and serum PSA: possible biopotential markers in human prostatic cancer. Urology 1996;48:261-8. [PMID: 8753738 DOI: 10.1016/S0090-4295(96)00169-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 45 |
Slebos RJ, Baas IO, Clement M, Polak M, Mulder JW, van den Berg FM, Hamilton SR, Offerhaus GJ. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer 1996;74:165-71. [PMID: 8688317 DOI: 10.1038/bjc.1996.333] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 46 |
Sameshima S, Kubota Y, Sawada T, Watanabe T, Kuroda T, Tsuno N, Higuchi Y, Shinozaki M, Sunouchi K, Masaki T, Saito Y, Muto T. Overexpression of p53 protein and histologic grades of dysplasia in colorectal adenomas. Dis Colon Rectum 1996;39:562-7. [PMID: 8620809 DOI: 10.1007/BF02058712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 47 |
Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB. p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 1996;25:249-55. [PMID: 8835823 DOI: 10.1111/j.1600-0714.1996.tb01380.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 48 |
Baretton GB, Vogt M, Müller C, Diebold J, Schneiderbanger K, Schmidt M, Löhrs U. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II). Scand J Gastroenterol 1996;31:481-9. [PMID: 8734346 DOI: 10.3109/00365529609006769] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 49 |
Kusama K, Okutsu S, Takeda A, Himiya T, Kojima A, Kidokoro Y, Chu L, Iwanari S, Kudo I, Moro I. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma. J Pathol 1996;178:415-21. [PMID: 8691320 DOI: 10.1002/(SICI)1096-9896(199604)178:4<415::AID-PATH548>3.0.CO;2-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 50 |
Zhu L, Kim K, Domenico DR, Appert HE, Howard JM. Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA. J Surg Oncol 1996;61:100-5. [PMID: 8606540 DOI: 10.1002/(SICI)1096-9098(199602)61:2<100::AID-JSO3>3.0.CO;2-G] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 51 |
Kashiwagi H, Spigelman AD, Talbot IC, Phillip RKS. Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis. Br J Surg 1996;83:225-8. [DOI: 10.1002/bjs.1800830223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 52 |
Sawada T. Early Diagnosis of Colon Cancer in Ulcerative Colitis. Digestive Endoscopy 1996;8:53-56. [DOI: 10.1111/j.1443-1661.1996.tb00414.x] [Reference Citation Analysis]
|
| 53 |
Karamitopoulou E, Perentes E, Diamantis I, Vogt U, Wegmann W. p53 protein expression in colorectal adenomas: an immunohistochemical study using an antigen retrieval system. Histopathology 1995;27:517-23. [PMID: 8838331 DOI: 10.1111/j.1365-2559.1995.tb00322.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 54 |
Hanski C. Is mucinous carcinoma of the colorectum a distinct genetic entity? Br J Cancer 1995;72:1350-6. [PMID: 8519644 DOI: 10.1038/bjc.1995.514] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 55 |
Garzetti GG, Ciavattini A, Lucarini G, Goteri G, De Nictolis M, Romanini C, Biagini G. Modulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after neoadjuvant combination chemotherapy. Eur J Obstet Gynecol Reprod Biol 1995;63:31-6. [PMID: 8674562 DOI: 10.1016/0301-2115(95)02216-t] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 56 |
Lee CS, Pirdas A, Lee MW. p53 in cutaneous melanoma: immunoreactivity and correlation with prognosis. Australas J Dermatol 1995;36:192-5. [PMID: 8593106 DOI: 10.1111/j.1440-0960.1995.tb00971.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 57 |
Nakopoulou L, Constantinides C, Papandropoulos J, Theodoropoulos G, Tzonou A, Giannopoulos A, Zervas A, Dimopoulos C. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy. Urology 1995;46:334-40. [PMID: 7660508 DOI: 10.1016/S0090-4295(99)80216-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 58 |
Volant A, Nousbaum JB, Giroux MA, Roué-Quintin I, Metges JP, Férec C, Gouérou H, Robaszkiewicz M. p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions. J Clin Pathol 1995;48:531-4. [PMID: 7665695 DOI: 10.1136/jcp.48.6.531] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 59 |
Luo JC, Neugut AI, Garbowski G, Forde KA, Treat M, Smith S, Carney WP, Brandt-Rauf PW. Levels of p53 antigen in the plasma of patients with adenomas and carcinomas of the colon. Cancer Lett 1995;91:235-40. [PMID: 7767914 DOI: 10.1016/0304-3835(95)03744-h] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 60 |
Ng IO, Lai EC, Chan AS, So MK. Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation. J Gastroenterol Hepatol 1995;10:250-5. [PMID: 7548799 DOI: 10.1111/j.1440-1746.1995.tb01089.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 61 |
Tomita T. DNA ploidy and proliferating cell nuclear antigen in colonic adenomas and adenocarcinomas. Dig Dis Sci 1995;40:996-1004. [PMID: 7729290 DOI: 10.1007/BF02064188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 62 |
Lee CS, Pirdas A. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathology 1995;27:117-20. [PMID: 7567135 DOI: 10.1080/00313029500169692] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 63 |
Nagao T, Kondo F, Sato T, Nagato Y, Kondo Y. Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining. Hum Pathol 1995;26:326-33. [PMID: 7890286 DOI: 10.1016/0046-8177(95)90066-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 64 |
Laurent-Puig P, Lubin R, Semhoun-Ducloux S, Pelletier G, Fourre C, Ducreux M, Briantais MJ, Buffet C, Soussi T. Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases. Gut 1995;36:455-8. [PMID: 7698709 DOI: 10.1136/gut.36.3.455] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 65 |
van Es JM, Polak MM, van den Berg FM, Ramsoekh TB, Craanen ME, Hruban RH, Offerhaus GJ. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product. J Clin Pathol 1995;48:218-22. [PMID: 7730480 DOI: 10.1136/jcp.48.3.218] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 66 |
Hasegawa H, Ueda M, Furukawa K, Watanabe M, Teramoto T, Mukai M, Kitajima M. p53 gene mutations in early colorectal carcinoma. De novo vs. adenoma-carcinoma sequence. Int J Cancer 1995;64:47-51. [PMID: 7665248 DOI: 10.1002/ijc.2910640110] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 1995;175:175-80. [PMID: 7738712 DOI: 10.1002/path.1711750204] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 68 |
Mulder JW, Wielenga VJ, Polak MM, van den Berg FM, Adolf GR, Herrlich P, Pals ST, Offerhaus GJ. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 1995;36:76-80. [PMID: 7534253 DOI: 10.1136/gut.36.1.76] [Cited by in Crossref: 38] [Cited by in F6Publishing: 50] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 69 |
Marks JR, Davidoff AM, Iglehart JD. p53 in Human Cancer. Cellular Cancer Markers 1995. [DOI: 10.1007/978-1-4757-2381-6_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 70 |
Jeffers MD, Richmond J, Farquharson M, McNicol AM. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium. J Clin Pathol 1994;47:1073-6. [PMID: 7876377 DOI: 10.1136/jcp.47.12.1073] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 71 |
Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, Tong TR, Laurin JN, Abraham JM, Greenwald BD, Meltzer SJ. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 1994;25:1069-74. [PMID: 7927312 DOI: 10.1016/0046-8177(94)90067-1] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 72 |
Hamana T, Kawai K, Serizawa A, Tsutsumi Y, Watanabe K. Immunohistochemical demonstration of p53 protein in colorectal adenomas and adenocarcinomas. Reliable application of the heat-induced antigen retrieval method to formalin-fixed, paraffin-embedded material. Pathol Int 1994;44:765-70. [PMID: 7834078 DOI: 10.1111/j.1440-1827.1994.tb02924.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 73 |
Kawai K, Serizawa A, Hamana T, Tsutsumi Y. Heat-induced antigen retrieval of proliferating cell nuclear antigen and p53 protein in formalin-fixed, paraffin-embedded sections. Pathol Int 1994;44:759-64. [PMID: 7834077 DOI: 10.1111/j.1440-1827.1994.tb02923.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 74 |
Lewis DJ, Sesterhenn IA, McCarthy WF, Moul JW. Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease. J Urol 1994;152:418-23. [PMID: 8015085 DOI: 10.1016/s0022-5347(17)32753-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 75 |
Goukon Y, Sasano H, Nishihira T, Mori S, Nagura H. p53 immunolocalization in cytology specimens: a study in human esophageal carcinoma. Diagn Cytopathol 1994;11:113-8. [PMID: 7813357 DOI: 10.1002/dc.2840110203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 76 |
Auvinen A, Isola J, Visakorpi T, Koivula T, Virtanen S, Hakama M. Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer 1994;70:293-6. [PMID: 8054278 DOI: 10.1038/bjc.1994.295] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 77 |
Pezzella F, Micklem K, Turley H, Pulford K, Jones M, Kocialkowski S, Delia D, Aiello A, Bicknell R, Smith K. Antibody for detecting p53 protein by immunohistochemistry in normal tissues. J Clin Pathol 1994;47:592-6. [PMID: 8089212 DOI: 10.1136/jcp.47.7.592] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 78 |
Meyer JS, He W. High proliferative rates demonstrated by bromodeoxyuridine labeling index in breast carcinomas with p53 overexpression. J Surg Oncol 1994;56:146-52. [PMID: 8028344 DOI: 10.1002/jso.2930560304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 79 |
Stephenson TJ, Royds JA, Silcocks PB, Brammer HJ, Shorthouse AJ, Underwood JC. Diagnostic associations of p53 immunostaining in fine needle aspiration cytology of the breast. Cytopathology 1994;5:146-53. [PMID: 7919057 DOI: 10.1111/j.1365-2303.1994.tb00410.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 80 |
Thomas DJ, Robinson MC, Charlton R, Wilkinson S, Shenton BK, Neal DE. P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder. Br J Urol 1994;73:533-7. [PMID: 8012776 DOI: 10.1111/j.1464-410x.1994.tb07639.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 81 |
Mellon K, Wilkinson S, Vickers J, Robinson MC, Shenton BK, Neal DE. Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder. Br J Urol 1994;73:522-5. [PMID: 8012774 DOI: 10.1111/j.1464-410x.1994.tb07637.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 82 |
Tomlinson FH, Jenkins RB, Scheithauer BW, Keelan PA, Ritland S, Parisi JE, Cunningham J, Olsen KD. Aggressive medulloblastoma with high-level N-myc amplification. Mayo Clin Proc 1994;69:359-65. [PMID: 8170180 DOI: 10.1016/s0025-6196(12)62221-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 83 |
Iino H, Fukayama M, Maeda Y, Koike M, Mori T, Takahashi T, Kikuchi-Yanoshita R, Miyaki M, Mizuno S, Watanabe S. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 1994;73:1324-31. [PMID: 7906606 DOI: 10.1002/1097-0142(19940301)73:5<1324::aid-cncr2820730503>3.0.co;2-w] [Cited by in Crossref: 69] [Cited by in F6Publishing: 80] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 84 |
Ng HK, Lo SY, Huang DP, Poon WS. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors. Pathology 1994;26:1-5. [PMID: 8165016 DOI: 10.1080/00313029400169001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 85 |
Saegusa M, Takano Y, Kishimoto H, Wakabayashi G, Nohga K, Okudaira M. Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach. J Cancer Res Clin Oncol 1993;119:737-44. [PMID: 8104947 DOI: 10.1007/BF01195346] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 86 |
Younes M, Lebovitz RM, Lechago LV, Lechago J. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. Gastroenterology 1993;105:1637-42. [PMID: 8253340 DOI: 10.1016/0016-5085(93)91058-p] [Cited by in Crossref: 145] [Cited by in F6Publishing: 154] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 87 |
Thomas DJ, Robinson M, King P, Hasan T, Charlton R, Martin J, Carr TW, Neal DE. p53 expression and clinical outcome in prostate cancer. Br J Urol 1993;72:778-81. [PMID: 8281412 DOI: 10.1111/j.1464-410x.1993.tb16267.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 88 |
Boag G, Lee CS, Charalambous D, Rode J. p53 expression in laryngeal carcinoma. Pathology 1993;25:394-7. [PMID: 8165006 DOI: 10.3109/00313029309090866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 89 |
Schwartz J, Shklar G, Trickler D. p53 in the anticancer mechanism of vitamin E. Eur J Cancer B Oral Oncol 1993;29B:313-8. [PMID: 11706428 DOI: 10.1016/0964-1955(93)90055-j] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 90 |
Lee CS, Rush M, Charalambous D, Rode J. Immunohistochemical demonstration of the p53 tumour suppressor gene product in cancer of the pancreas and chronic pancreatitis. J Gastroenterol Hepatol 1993;8:465-9. [PMID: 8218996 DOI: 10.1111/j.1440-1746.1993.tb01550.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 91 |
Shimaya K, Shiozaki H, Inoue M, Tahara H, Monden T, Shimano T, Mori T. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch A Pathol Anat Histopathol 1993;422:271-6. [PMID: 8506620 DOI: 10.1007/BF01608335] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 92 |
Burns JE, Baird MC, Clark LJ, Burns PA, Edington K, Chapman C, Mitchell R, Robertson G, Soutar D, Parkinson EK. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993;67:1274-84. [PMID: 8390283 DOI: 10.1038/bjc.1993.238] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 93 |
Aka K, Bruner JM, Bondy ML, Ligon K, Nishi T, del Giglio A, Moser RP, Levin VA, Saya H. Detection of p53 alterations in human astrocytomas using frozen tissue sections for the polymerase chain reaction. J Neurooncol 1993;16:125-33. [PMID: 7904621 DOI: 10.1007/BF01324699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 94 |
Scott N, Bell SM, Sagar P, Blair GE, Dixon MF, Quirke P. p53 expression and K-ras mutation in colorectal adenomas. Gut 1993;34:621-4. [PMID: 8504962 DOI: 10.1136/gut.34.5.621] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 95 |
Taylor HW, Boyle M, Smith SC, Bustin S, Williams NS. Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis. Br J Surg 1993;80:442-4. [PMID: 8495305 DOI: 10.1002/bjs.1800800411] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 96 |
Scott N, Quirke P. Molecular biology of colorectal neoplasia. Gut 1993;34:289-92. [PMID: 8472973 DOI: 10.1136/gut.34.3.289] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 97 |
Bártek J, Bártková J, Lukás J, Stasková Z, Vojtĕsek B, Lane DP. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol 1993;169:27-34. [PMID: 8433213 DOI: 10.1002/path.1711690106] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 98 |
Holm R, Skomedal H, Helland A, Kristensen G, Børresen AL, Nesland JM. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri. J Pathol 1993;169:21-6. [PMID: 8433212 DOI: 10.1002/path.1711690105] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 99 |
Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, Taylor GR, Dixon MF, Quirke P. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993;104:57-64. [PMID: 8419262 DOI: 10.1016/0016-5085(93)90835-z] [Cited by in Crossref: 170] [Cited by in F6Publishing: 190] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 100 |
Hanski C, Bornhoeft G, Shimoda T, Hanski ML, Lane DP, Stein H, Riecken EO. Expression of p53 protein in invasive colorectal carcinomas of different histologic types. Cancer 1992;70:2772-7. [PMID: 1451054 DOI: 10.1002/1097-0142(19921215)70:12<2772::aid-cncr2820701208>3.0.co;2-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 101 |
Sun XF, Carstensen JM, Zhang H, Stål O, Wingren S, Hatschek T, Nordenskjöld B. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992;340:1369-73. [PMID: 1360088 DOI: 10.1016/0140-6736(92)92558-w] [Cited by in Crossref: 157] [Cited by in F6Publishing: 180] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 102 |
Mayall FG, Goddard H, Gibbs AR. p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. J Pathol 1992;168:377-81. [PMID: 1484319 DOI: 10.1002/path.1711680407] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 103 |
Stephenson TJ, Royds J, Silcocks PB, Bleehen SS. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol 1992;127:566-70. [PMID: 1476915 DOI: 10.1111/j.1365-2133.1992.tb14866.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 104 |
Tobal K, Warren W, Cooper CS, McCartney A, Hungerford J, Lightman S. Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 1992;66:900-4. [PMID: 1419633 DOI: 10.1038/bjc.1992.382] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 105 |
Laurent-Puig P, Flejou JF, Fabre M, Bedossa P, Belghiti J, Gayral F, Franco D. Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. Hepatology 1992;16:1171-5. [PMID: 1330867] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 106 |
Barbareschi M, Iuzzolino P, Pennella A, Allegranza A, Arrigoni G, Dalla Palma P, Doglioni C. p53 protein expression in central nervous system neoplasms. J Clin Pathol 1992;45:583-6. [PMID: 1355494 DOI: 10.1136/jcp.45.7.583] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 107 |
Remvikos Y, Tominaga O, Hammel P, Laurent-Puig P, Salmon RJ, Dutrillaux B, Thomas G. Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer 1992;66:758-64. [PMID: 1419618 DOI: 10.1038/bjc.1992.352] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 108 |
McLaren R, Kuzu I, Dunnill M, Harris A, Lane D, Gatter KC. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 1992;66:735-8. [PMID: 1329907 DOI: 10.1038/bjc.1992.348] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 109 |
Gupta RK, Norton AJ, Thompson IW, Lister TA, Bodmer JG. p53 expression in Reed-Sternberg cells of Hodgkin's disease. Br J Cancer 1992;66:649-52. [PMID: 1419601 DOI: 10.1038/bjc.1992.331] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 110 |
Warnakulasuriya KA, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 1992;21:404-8. [PMID: 1432735 DOI: 10.1111/j.1600-0714.1992.tb01028.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 111 |
Lemoine NR, Hughes CM, Cowell JK. Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours. J Pathol 1992;168:237-42. [PMID: 1334142 DOI: 10.1002/path.1711680213] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 112 |
Lehtinen T, Isola J, Aine R, Alavaikko M, Lehtinen M. Accumulation of p53 protein correlates with tumour proliferative activity in EBV positive Burkitt's lymphoma. Hematol Oncol 1992;10:273-9. [PMID: 1337333 DOI: 10.1002/hon.2900100505] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 113 |
Jankowski J, Coghill G, Hopwood D, Wormsley KG. Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. Gut 1992;33:1033-8. [PMID: 1398227 DOI: 10.1136/gut.33.8.1033] [Cited by in Crossref: 101] [Cited by in F6Publishing: 112] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 114 |
Thompson SJ, Mellon K, Charlton RG, Marsh C, Robinson M, Neal DE. P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Br J Urol 1992;69:609-13. [PMID: 1379102 DOI: 10.1111/j.1464-410x.1992.tb15632.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 115 |
Pignatelli M, Stamp GW, Kafiri G, Lane D, Bodmer WF. Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 1992;50:683-8. [PMID: 1347513 DOI: 10.1002/ijc.2910500503] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 116 |
Barbareschi M, Girlando S, Mauri FA, Arrigoni G, Laurino L, Palma PD, Doglioni C. Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol 1992;166:343-50. [DOI: 10.1002/path.1711660405] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 117 |
Villuendas R, Piris MA, Orradre JL, Mollejo M, Algara P, Sanchez L, Martinez JC, Martinez P. P53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol 1992;166:235-41. [PMID: 1381424 DOI: 10.1002/path.1711660305] [Cited by in Crossref: 68] [Cited by in F6Publishing: 76] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 118 |
Mellon K, Thompson S, Charlton RG, Marsh C, Robinson M, Lane DP, Harris AL, Horne CW, Neal DE. p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant Prostate. Journal of Urology 1992;147:496-9. [DOI: 10.1016/s0022-5347(17)37287-7] [Cited by in Crossref: 121] [Cited by in F6Publishing: 99] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 119 |
Davidoff AM, Kerns BJ, Pence JC, Marks JR, Iglehart JD. p53 alterations in all stages of breast cancer. J Surg Oncol 1991;48:260-7. [PMID: 1745051 DOI: 10.1002/jso.2930480409] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 120 |
Bártková J, Bártek J, Lukás J, Vojtĕsek B, Stasková Z, Rejthar A, Kovarík J, Midgley CA, Lane DP. p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 1991;49:196-202. [PMID: 1652567 DOI: 10.1002/ijc.2910490209] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 121 |
Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CH, Neal DE. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 1991;63:967-70. [PMID: 1712624 DOI: 10.1038/bjc.1991.211] [Cited by in Crossref: 135] [Cited by in F6Publishing: 145] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 122 |
Gannon JV, Lane DP. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 1991;349:802-6. [PMID: 2000149 DOI: 10.1038/349802a0] [Cited by in Crossref: 129] [Cited by in F6Publishing: 144] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 123 |
Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 1991;63:317-9. [PMID: 1997114 DOI: 10.1038/bjc.1991.74] [Cited by in Crossref: 149] [Cited by in F6Publishing: 166] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 124 |
Mørkve O, Høstmark J. Influence of tissue preparation techniques on p53 expression in bronchial and bladder carcinomas, assessed by immunofluorescence staining and flow cytometry. Cytometry 1991;12:622-7. [PMID: 1782831 DOI: 10.1002/cyto.990120706] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 125 |
Mørkve O, Laerum OD. Flow cytometric measurement of p53 protein expression and DNA content in paraffin-embedded tissue from bronchial carcinomas. Cytometry 1991;12:438-44. [PMID: 1935458 DOI: 10.1002/cyto.990120509] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 126 |
Cheng J, Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990;10:5502-9. [PMID: 2144611 DOI: 10.1128/mcb.10.10.5502-5509.1990] [Cited by in Crossref: 186] [Cited by in F6Publishing: 184] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 127 |
Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 1990;87:7555-9. [PMID: 1699228 DOI: 10.1073/pnas.87.19.7555] [Cited by in Crossref: 629] [Cited by in F6Publishing: 712] [Article Influence: 19.1] [Reference Citation Analysis]
|
| 128 |
Cheng J, Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990;10:5502-9. [PMID: 2144611 DOI: 10.1128/mcb.10.10.5502-5509.1990] [Cited by in Crossref: 10] [Cited by in F6Publishing: 86] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 129 |
Muleris M, Salmon RJ, Dutrillaux B. Cytogenetics of colorectal adenocarcinomas. Cancer Genet Cytogenet 1990;46:143-56. [PMID: 2340486 DOI: 10.1016/0165-4608(90)90100-o] [Cited by in Crossref: 101] [Cited by in F6Publishing: 109] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 130 |
Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990;9:1595-602. [PMID: 1691710 DOI: 10.1002/j.1460-2075.1990.tb08279.x] [Cited by in Crossref: 652] [Cited by in F6Publishing: 633] [Article Influence: 19.8] [Reference Citation Analysis]
|
| 131 |
Wright EC, Goldgar DE, Fain PR, Barker DF, Skolnick MH. A genetic map of human chromosome 17p. Genomics 1990;7:103-9. [PMID: 2335351 DOI: 10.1016/0888-7543(90)90524-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 132 |
Remvikos Y, Laurent-Puig P, Salmon RJ, Frelat G, Dutrillaux B, Thomas G. Simultaneous monitoring of P53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer 1990;45:450-6. [PMID: 2137812 DOI: 10.1002/ijc.2910450313] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 1.6] [Reference Citation Analysis]
|
